EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories

Stuart J Moat iD, James R Bonham iD, Christine Cavanagh, Margaret Birch, Caroline Griffith, Lynette Shakespeare iD, Clare Le Masurier, Claire Manfredonia, Beverly Hird iD, Philippa Goddard, Sarah Smith, Laura Wainwright und 13 weitere

International Journal of Neonatal Screening · 05.09.2024 · 10 (3) · 60

DOI: 10.3390/ijns10030060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 05.09.2024. Verfasst von Stuart J Moat und 24 weiteren Autor:innen. Beteiligte Einrichtung: Wales Newborn Screening Laboratory, Department of Medical Biochemistry, Immunology & Toxicology, University Hospital of Wales, Cardiff CF14 4XW, UK. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2015, U.K. newborn screening (NBS) laboratory guidelines were introduced to standardize dried blood spot (DBS) specimen quality acceptance and specify a minimum acceptable DBS diameter of ≥7 mm. The UK ‘acceptable’ avoidable repeat rate (AVRR) is ≤2%. To assess inter-laboratory variability in specimen acceptance/rejection, two sets of colored scanned images (n = 40/set) of both good and poor-quality DBS specimens were distributed to all 16 U.K. NBS laboratories for evaluation as part of an external quality assurance (EQA) assessment. The mean (range) number of specimens rejected in the first EQA distribution was 7 (1–16) and in the second EQA distribution was 7 (0–16), demonstrating that adherence to the 2015 guidelines was highly variable. A new minimum standard for DBS size of ≥8 mm (to enable a minimum of six sub-punches from two DBS) was discussed. NBS laboratories undertook a prospective audit and demonstrated that using ≥8 mm as the minimum acceptable DBS diameter would increase the AVRR from 2.1% (range 0.55% to 5.5%) to 7.8% (range 0.55% to 22.7%). A significant inverse association between the number of specimens rejected in the DBS EQA distributions and the predicted AVVR (using ≥8 mm minimum standard) was observed (r = −0.734, p = 0.003). Before implementing more stringent standards, the impact of a standard operating procedure (SOP) designed to enable a standardized approach of visual assessment and using the existing ≥7 mm diameter (to enable a minimum of four sub-punches from two DBS) as the minimum standard was assessed in a retrospective audit. Implementation of the SOP and using the ≥7 mm DBS diameter would increase the AVRR from 2.3% (range 0.63% to 5.3%) to 6.5% (range 4.3% to 20.9%). The results demonstrate that there is inconsistency in applying the acceptance/rejection criteria, and that a low AVVR is not an indication of good-quality specimens being received into laboratories. Further work is underway to introduce and maintain standards without increasing the AVRR to unacceptable levels.

Schlagwörter

Stichwörter der Autor:innen

avoidable repeat rateblood spot qualitydried blood spotsexternal quality assessmentfilter paperspecimen collectionspecimen collection device

Autor:innen und Institutionen

  • Wales Newborn Screening Laboratory, Department of Medical Biochemistry, Immunology & Toxicology, University Hospital of Wales, Cardiff CF14 4XW, UK.
  • University Hospital Wales, School of Medicine, Cardiff University, Cardiff CF14 4XW, UK.
  • Clinical Chemistry, Sheffield Children's NHSFT, Sheffield S10 2TH, UK.
  • NHS England, Wellington House, London SE1 8UG, UK.
  • Health Protection & Screening Services, Public Health Wales, Cardiff CF10 4BZ, UK.
  • Biochemical Genetics, Specialist Laboratory Medicine, St James University Hospital, Leeds LS9 7TF, UK.

ORCID-Profile: Stuart J Moat, James R Bonham, Lynette Shakespeare, Beverly Hird, Rachel S Carling, Nick Flynn, Mehdi Mirzazadeh, Lesley Tetlow

Zitieren

APA

Moat, S. J., Bonham, J. R., Cavanagh, C., Birch, M., Griffith, C., Shakespeare, L., Le Masurier, C., Manfredonia, C., Hird, B., Goddard, P., Smith, S., Wainwright, L., Carling, R. S., Cundick, J., Jenkinson, F., Collingwood, C., Flynn, N., Taj, N., Mirzazadeh, M., …, & Tetlow, L. (2024). Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories. International Journal of Neonatal Screening, 10(3), 60. https://doi.org/10.3390/ijns10030060

Vancouver

Moat SJ, Bonham JR, Cavanagh C, Birch M, Griffith C, Shakespeare L, et al. Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories. International Journal of Neonatal Screening. 2024;10(3):60. doi:10.3390/ijns10030060

BibTeX
@article{Moat2024,
  author = {Moat, Stuart J and Bonham, James R and Cavanagh, Christine and Birch, Margaret and Griffith, Caroline and Shakespeare, Lynette and Le Masurier, Clare and Manfredonia, Claire and Hird, Beverly and Goddard, Philippa and Smith, Sarah and Wainwright, Laura and Carling, Rachel S and Cundick, Jennifer and Jenkinson, Fiona and Collingwood, Catherine and Flynn, Nick and Taj, Nazia and Mirzazadeh, Mehdi and Ramgoolam, Tejswurree and Robinson, Liz and Headley, Amy and Morgan, Tessa and Elliman, David and Tetlow, Lesley},
  title = {Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories},
  journal = {International Journal of Neonatal Screening},
  year = {2024},
  volume = {10},
  number = {3},
  pages = {60},
  doi = {10.3390/ijns10030060}
}
Kostenlos starten →